Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hookipa Biotech GmbH
Revolution Medicines, Inc.
UNICANCER
Advaxis, Inc.
Innovent Biologics (Suzhou) Co. Ltd.
Genmab
Revolution Medicines, Inc.
VA Office of Research and Development
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Anandasabapathy, Sharmila, M.D.
University of Pittsburgh
Duke University
Merck KGaA, Darmstadt, Germany
Genmab
Access Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
AstraZeneca